UgenTec Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
16

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
9
UgenTec General Information
Description
Developer of SaaS-based molecular diagnostics software intended for sample orchestration, result calling, quality control (QC) and lab intelligence. The company's software intelligently analyzes raw PCR data from multiple commercial devices, resulting in a more reliable measurement and enabling laboratories to automate and standardize their workflow.
Contact Information
Website
www.ugentec.comCorporate Office
- Kempische Steenweg 303/105
- 3500 Hasselt
- Belgium
Corporate Office
- Kempische Steenweg 303/105
- 3500 Hasselt
- Belgium
UgenTec Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
UgenTec Comparisons
Industry
Financing
Details
UgenTec Competitors (31)
One of UgenTec’s 31 competitors is Fabric Genomics, a Venture Capital-Backed company based in Oakland, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Fabric Genomics | Venture Capital-Backed | Oakland, CA | ||||
Synthace | Venture Capital-Backed | London, United Kingdom | ||||
Genoox | Private Equity-Backed | Palo Alto, CA | ||||
SnapGene | Private Equity-Backed | Boston, MA | ||||
Genestack | Corporation | Cambridge, United Kingdom |
UgenTec Patents
UgenTec Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023272292-A1 | A computer controlled method for analyzing molecular time series data, a related system and related devices | Pending | 17-May-2022 | ||
US-20250117553-A1 | Computer controlled method for analyzing molecular time series data, a related sytem and related devices | Pending | 17-May-2022 | ||
EP-4526888-A1 | A computer controlled method for analyzing molecular time series data, a related system and related devices | Pending | 17-May-2022 | ||
EP-3129500-A1 | Methods for fluorescence data correction | Active | 11-Apr-2014 | ||
EP-3129500-B1 | Methods for fluorescence data correction | Active | 11-Apr-2014 | G16B25/20 |
UgenTec Signals
UgenTec Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
UgenTec FAQs
-
When was UgenTec founded?
UgenTec was founded in 2014.
-
Where is UgenTec headquartered?
UgenTec is headquartered in Hasselt, Belgium.
-
What is the size of UgenTec?
UgenTec has 16 total employees.
-
What industry is UgenTec in?
UgenTec’s primary industry is Enterprise Systems (Healthcare).
-
Is UgenTec a private or public company?
UgenTec is a Private company.
-
What is UgenTec’s current revenue?
The current revenue for UgenTec is
. -
How much funding has UgenTec raised over time?
UgenTec has raised $16.6M.
-
Who are UgenTec’s investors?
Summa Equity has invested in UgenTec.
-
Who are UgenTec’s competitors?
Fabric Genomics, Synthace, Genoox, SnapGene, and Genestack are some of the 31 competitors of UgenTec.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »